Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Meiji Seika claims bicyclic thiazoles for CNS disorders

Aug. 16, 1996

Allelix describes D4 antagonists for schizophrenia

Aug. 16, 1996

BTS-73947: new D1/D5 antagonist from Knoll

Aug. 16, 1996

Roche profiles pharmacokinetics, pharmacodynamics of new benzodiazepine

Aug. 16, 1996

first clinical study results reported for Ro-48-6791

Aug. 16, 1996

LY-23728, 5-HT2B antagonist reported by Lilly

Aug. 16, 1996

5-HT2 receptor ligands reported by Allelix

Aug. 16, 1996

Histamine H3 agonist increases slow-wave sleep in rats

Aug. 16, 1996

VML-251 phase IIa results reported

Aug. 16, 1996

Ono claims PGE2 agonists and antagonists

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...